Novel experimental and early investigational drugs for the treatment of bipolar disorder.
Mauro Giovanni CartaGoce KalcevMichele FornaroAntonio Egidio NardiPublished in: Expert opinion on investigational drugs (2021)
Regardless of the neurobiological pathways worthy of investigation toward the development of experimental drugs for BD, several unmet needs need to be addressed first. In particular, several biomarkers are altered in BD. However, it is the opinion herein expressed by the authors that it remains uncertain what comes first, that is peripheral changes or the disease.